Peroral drug delivery systems for peptides and proteins

S.T.P. Pharma Sciences

Volumn 12, Issue 4, 2002, Pages 213-221

  Dorkoosh, F A ^a   Verhoef, J C ^a   Rafiee Tehrani, M ^a   Borchard, G ^a   Junginger, H E ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Absorption enhancers; Carrier systems; Enzyme inhibitors; Oral drug delivery systems; Peptide drug delivery

Indexed keywords

ALPHA 2 MACROGLOBULIN; APROTININ; BESTATIN; CARBOMER; CHITOSAN; CHOLIC ACID; CHYMOSTATIN; DEOXYCHOLATE SODIUM; DODECYL SULFATE SODIUM; ENZYME INHIBITOR; INSULIN; LEUPEPTIN; LIPOSOME; LYSOZYME; MICROSPHERE; NANOCAPSULE; NANOPARTICLE; OCTREOTIDE; OLEIC ACID; PEPTIDE; POLYACRYLIC ACID; POLYCARBOPHIL; POLYMER; POLYOXYETHYLENE DERIVATIVE; PROTEIN; PROTEINASE;

DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG PELLET; HUMAN; HYDROGEL; MICROEMBOLISM; NONHUMAN; REVIEW; TABLET;

EID: 0036656814     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Rahman Y.E. -Studies on liposomes (lipid spherules) prepared from mitochondrial and microsomal phospholipids. Their surface charge and their interactions with various proteins. - ANL. Rep., 225-226, 1969.
2. Saffran M., Pansky B., Budd G.C., Williams F.E. -Insulin and the gastrointestinal tract. - J. Control. Rel., 46, 89-98, 1997.
3. Vyas S.P., Venugopalan P., Sood A., Mysore N. -Some approaches to improve bioavailability of peptides and proteins through oral and other mucosal routes. - Pharmazie, 52, 339-345, 1997.
4. Davis S.S. - Delivery systems for biopharmaceuticals. - J. Pharm. Pharmacol., 44, 186-190, 1992.
5. Fix J.A. - Oral controlled release technology for peptides: status and future prospects. - Pharm. Res., 13, 1760-1764, 1996.
6. Fasano A. - Innovative strategies for the oral delivery of drugs and peptides. - Trends Biotechnol., 16, 152-157, 1998.
7. Langguth P., Bohner V., Heizmann J., Merkle H.P., Wolffram S., Amidon G.L., Yamashita S. - The challenge of proteolytic enzymes in intestinal peptide delivery. - J. Control. Rel., 46, 39-57, 1997.
8. Zhou X. H. - Overcoming enzymatic and absorption barriers to non-parenterally administered protein and peptide drugs. - J. Control. Rel., 29, 239-252, 1994.
9. Bernkop-Schnürch A. - The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. - J. Control. Rel., 52, 1-16, 1998.
10. Aungst B.J. - Intestinal permeation enhancers. - J. Pharm. Sci., 89, 429-442, 2000.
11. Bernkop-Schnürch A. - Chitosan and its derivatives: potential excipients for peroral peptide delivery systems. - Int. J. Pharm., 194, 1-13, 2000.
12. Fix J.A. - Strategies for delivery of peptides utilizing absorption-enhancing agents. - J. Pharm. Sci., 85, 1282-1285, 1996.
13. Bai J.P., Chang L.L., Guo J.H. - Targeting of peptide and protein drugs to specific sites in the oral route. - Crit. Rev. Ther. Drug Carrier Syst., 12, 339-371, 1995.
14. Lindahl A., Ungell A.L., Knutson L., Lennernas H. -Characterization of fluids from the stomach and proximal jejunum in men and women. - Pharm. Res., 14, 497-502, 1997.
15. Kratzel M., Hiessbock R., Bernkop-Schnürch A. -Auxiliary agents for the peroral administration of peptide and protein drugs: synthesis and evaluation of novel pepstatin analogues. - J. Med. Chem., 41, 2339-2344, 1998.
16. Bai J.P. - Distribution of brush-border membrane peptidases along the rabbit intestine: implication for oral delivery of peptide drugs. - Life Sci., 52, 941-947, 1993.
17. Thwaites D.T., Hirst B.H., Simmons N.L. - Passive transepithelial absorption of thyrotropin-releasing hormone (TRH) via a paracellular route in cultured intestinal and renal epithelial cell lines. - Pharm. Res., 10, 674-681, 1993.
18. Daugherty A.L., Mrsny R.J. - Regulation of the intestinal epithelial paracellular barrier. - Pharm. Sci. Technol. Today, 2, 281-287, 1999.
19. Su S.F., Amidon G.L. - Investigation into the intestinal metabolism of [D-Ala1] peptide T amide: implication for oral drug delivery. - Biochim. Biophys. Acta, 1245, 62-68, 1995.
20. Uraizee S.A., McPhillips A.M., Sakr A.A., Ritschel W.A. - Evaluation of absorption enhancers and enzyme inhibitors for the protection of human insulin. - Pharm. Ind., 61, 259-262, 1999.
21. Bernkop-Schnürch A., Scerbe-Saiko A. - Synthesis and in vitro evaluation of chitosan-EDTA-protease-inhibitor conjugates which might be useful in oral delivery of peptides and proteins. - Pharm. Res., 15, 263-269, 1998.
22. Bernkop-Schnürch A., Krajicek M.E. - Mucoadhesive polymers as platform for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates. - J. Control. Rel., 50, 215-223, 1998.
23. Sinko P.J., Lee Y.H., Makhey V., Leesman G.D., Sutyak J.P., Yu H., Perry B., Smith C.L., Hu P., Wagner E.J., Falzone L.M., McWhorter L.T., Gilligan J.P., Stern W. - Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT). - Pharm. Res., 16, 527-533, 1999.
24. Pappenheimer J.R., Dahl C.E., Karnovsky M.L., Maggio J.E. - Intestinal absorption and excretion of octapeptides composed of D-amino acids. - Proc. Natl. Acad. Sci. USA, 91, 1942-1945, 1994.
25. Luessen H.L., Verhoef J.C., Borchard G., Lehr C.-M., De Boer A.G., Junginger H.E. - Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin. - Pharm. Res., 12, 1293-1298, 1995.
26. Ho H.O., Hsiao C.C., Sheu M.T. - Preparation of microemulsions using polyglycerol fatty acid esters as surfactant for the delivery of protein drugs. - J. Pharm. Sci., 85, 138-143, 1996.
27. Junginger H.E., Verhoef J.C. - Macromolecules as safe penetration enhancers for hydrophilic drugs - a fiction? - Pharm. Sci. Technol. Today, 1, 370-376, 1998.
28. Thanou M., Verhoef J.C., Marbach P., Junginger H.E. - Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo. - J. Pharm. Sci., 89, 951-957, 2000.
29. Michael S., Thöle M., Dillmann R., Fahr A., Drewe J., Fricker G. - Improvement of intestinal peptide absorption by synthetic bile acid derivative, cholylsarcosine. - Eur. J. Pharm. Sci., 10, 133-140, 2000.
30. Hosny E.A., Ghilzai N.M.K., Elmazar M.M. - Promotion of oral insulin absorption in diabetic rabbits using pH-dependent coated capsules containing sodium cholate. - Pharm. Acta Helv., 72, 203-207, 1997.
31. Dorkoosh F.A., Setyaningsih D., Borchard G., Rafiee-Tehrani M., Verhoef J.C., Junginger H.E. -Effects of superporous hydrogels on paracellular drug permeability and cytotoxicity studies in Caco-2 cell monolayers. - Int. J. Pharm., 241, 35-45, 2002.
32. Dorkoosh F.A., Borchard G., Rafiee-Tehrani M., Verhoef J.C., Junginger H.E. - Evaluation of superporous hydrogel (SPH) and SPH composite in porcine intestine ex vivo: assessment of drug transport, morphology effect, and mechanical fixation to intestinal wall. - Eur. J. Pharm. Biopharm., 53, 161-166, 2002.
33. Delie F., Letourneux Y., Nisato D., Puisieux F., Couvreur P. - Oral administration of peptides: study of a glycerolipidic prodrug. - Int. J. Pharm., 115, 45-52, 1995.
34. Asada H., Douen T., Waki M., Adachi S., Fujita T., Yamamoto A., Muranishi S. - Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine. - J. Pharm. Sci., 84, 682-687, 1995.
35. Hashimoto T., Nomoto M., Komatsu K., Haga M., Hayashi M. - Improvement of intestinal absorption of peptides: adsorption of B1-Phe monoglucosylated insulin to rat intestinal brush-border membrane vesicles. - Eur. J. Pharm. Biopharm., 50, 197-204, 2000.
36. Liu D., Huang L. - pH-sensitive, plasma-stable liposomes with relatively prolonged residence in circulation. - Biochim. Biophys. Acta, 1022, 348-355, 1990.
37. nd ed., 1993, pp. 1-14.
38. Choudhari K.B., Labhasetwar V., Dorle A.K. -Liposomes as a carrier for oral administration of insulin: effect of formulation factors. - J. Microencap., 11, 319-325, 1994.
39. Kisel M.A., Kulik L.N., Tsybovsky I.S., Vlasov A.P., Vorob'yov M.S., Kholodova E.A., Zabarovskaya Z.V. - Liposomes with phophatidylethanol as a carrier for oral delivery of insulin: studies in the rat. - Int. J. Pharm., 216, 105-114, 2001.
40. Spangler R.S. - Insulin administration via liposomes. -Diabetes Care, 13, 911-922, 1990.
41. Campbell P., Triebwasser K., Gerich J. - A comparison of regular insulin and vesicle encapsulated insulin on glucose metabolism in diabetic subjects. - Int. J. Clin. Pharmacol. Ther. Toxicol., 24, 658-660, 1986.
42. Mollee H., De Vrind J., De Vringer T. - Stable reversed vesicles in oil: Characterization studies and encapsulation of model compounds. - J. Pharm. Sci., 89, 930-939, 2000.
43. Marschütz M.K., Caliceti P., Bernkop-Schnürch A. - Design and in vivo evaluation of an oral delivery system for insulin. - Pharm. Res., 17, 1468-1474, 2000.
44. Ziv E., Kidron M., Raz I., Krausz M., Blatt Y., Rotman A., Bar-On H. - Oral administration of insulin in solid form to non-diabetic and diabetic dogs. - J. Pharm. Sci., 83, 792-794, 1994.
45. Tozaki H., Nishioka J., Komoike J., Okada N., Fujita T., Muranishi S., Kim S.I., Terashima H., Yamamoto A. -Enhanced absorption of insulin and (Asu(1,7))eel-calcitonin using novel azopolymer-coated pellets for colon-specific drug delivery.- J. Pharm. Sci., 90, 89-97, 2001.
46. Couvreur P., Puisieux F. - Nano- and microparticles for the delivery of polypeptides and proteins. - Adv. Drug Deliv. Rev., 10, 141-162, 1993.
47. Saffran M., Kumar G.S., Neckers D.C., Pena J., Jones R.H., Field J.B. - Biodegradable azopolymer coating for oral delivery of peptide drugs. - Biochem. Soc. Trans., 18, 752-754, 1990.
48. Tozaki H., Komoike J., Tada C., Maruyama T., Terabe A., Suzuki T., Yamamoto A., Muranishi S. - Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon. - J. Pharm. Sci., 86, 1016-1021, 1997.
49. Aboubakar M., Couvreur P., Pinto-Alphandary H., Gouritin B., Lacour B., Farinotti R., Puisieux F., Vauthier C. - Insulin-loaded nanocapsules for oral administration: In vitro and in vivo investigation. - Drug Develop. Res., 49, 109-117, 2000.
50. Damgé C., Michel C., Aprahamian M., Couvreur P., Devissaguet J.P. - Nanocapsules as carriers for oral peptide delivery. - J. Control. Rel., 13, 233-239, 1990.
51. Jung T., Kamm W., Breitenbach A., Kaiserling E., Xiao J.X., Kissel T. - Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? - Eur. J. Pharm. Biopharm., 50, 147-160, 2000.
52. Sakuma S., Suzuki N., Kikuchi H., Hiwatari K., Arikawa K., Kishida A., Akashi M. - Oral peptide delivery using nanoparticles composed of novel graft copolymers having hydrophobic backbone and hydrophilic branches. - Int. J. Pharm., 149, 93-106, 1997.
53. Li J.K., Wang N., Wu X.S. - A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery. - J. Pharm. Sci., 86, 891-895, 1997.
54. Couvreur P., Lenaerts V., Kante B., Roland M., Speiser P.P. - Oral and parenteral administration of insulin associated to hydrolysable nanoparticles. - Acta Pharm. Technol., 26, 220-222, 1980.
55. Kotzé A.F., Luessen H.L., De Boer A.G., Verhoef J.C., Junginger H.E. - Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments. - Eur. J. Pharm. Sci., 7, 145-151, 1999.
56. Luessen H.L., Lehr C.-M., Rentel C.-O., Noach A.B.J., De Boer A.G., Verhoef J.C., Junginger H.E. -Bioadhesive polymers for the peroral delivery of peptide drugs. - J. Control. Rel., 29, 329-338, 1994.
57. Luessen H.L., De Leeuw B.J., Langemeÿer M.W., De Boer A.G., Verhoef J.C., Jung Inger H.E. - Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. - Pharm. Res., 13, 1668-1672, 1996.
58. Thanou M., Verhoef J.C., Verheijden J.H.M., Junginger H.E. - Intestinal absorption of octreotide using trimethyl chitosan chloride: studies in pigs. - Pharm. Res., 18, 823-828, 2001.
59. Thanou M., Florea B.I., Langemeÿer M.W., Verhoef J.C., Junginger H.E. - N-trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-2 cells) and in vivo (rats). - Pharm. Res., 17, 27-31, 2000.
60. Trenktrog T., Müller B.W. - Preparation and characterization of a peptide containing w/o emulsion.- Int. J. Pharm., 123, 199-207, 1995.
61. Sarciaux J.M., Acar L., Sado P.A. - Using microemulsion formulations for oral drug delivery of therapeutic peptides. - Int. J. Pharm., 120, 127-136, 1995.
62. Constantinides P.P., Lancaster C.M., Marcello J., Chiossone D.C., Orner D., Hidalgo I., Smith P.L., Sarkahian A.B., Yiv S.H., Owen A.J. - Enhanced intestinal absorption of a RGD peptide from water-in-oil microemulsions of different composition and particle size. - J. Control. Rel., 34, 109-116, 1995.
63. Gabor F., Bernkop-Schnürch A., Hamilton G. -Bioadhesion to the intestine by means of E.coli K99-fimbriae: gastrointestinal stability and specificity of adherence. - Eur. J. Pharm. Sci., 5, 233-242, 1997.
64. Bernkop-Schnürch A., Gabor F., Szostak M.P., Lubitz W. - An adhesive drug delivery system based on K99-fimbriae. - Eur. J. Pharm. Sci., 3, 293-299, 1995.
65. Lehr C.-M. - Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract. - Crit. Rev. Ther. Drug Carrier Syst., 11, 119-160, 1994.
66. Zhou S.B., Deng X.M., Li X.H. - Investigation on a novel core-coated microspheres proteins delivery system. - J. Control. Rel., 75, 27-36, 2001.
67. Dorkoosh F.A., Verhoef J.C., Borchard G., Rafiee-Tehrani M., Junginger H.E. - Development and characterization of a novel peroral peptide drug delivery system. - J. Control. Rel., 71, 307-318, 2001.
68. Chen J., Park K. - Synthesis and characterization of superporous hydrogel composites. - J. Control. Rel., 65, 73-82, 2000.
69. Dorkoosh F.A., Brussee J., Verhoef J.C., Borchard G., Rafiee-Tehrani M., Junginger H.E. - Preparation and NMR characterisation of superporous hydrogels (SPH) and SPH composites. - Polymer, 41, 8213-8220, 2000.
70. Luessen H.L., Verhoef J.C., Borchard G., Lehr C.-M., De Boer A.G., Junginger H.E. - Carbomer and polycarbopbil are potent inhibitors of the intestinal proteolytic enzyme trypsin. - Pharm. Res., 12, 1293-1298, 1995.
71. Dorkoosh F.A., Verhoef J.C., Verheijden J.H.M., Rafiee-Tehrani M., Borchard G., Junginger H.E. -Peroral absorption of octreotide in pigs formulated in delivery systems on the basis of superporous hydrogel polymers. -Pharm. Res., 19, 1532-1534, 2002.